RADIOTHERAPY AND ONCOLOGY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
RADIOTHERAPY AND ONCOLOGY
RADIOTHER ONCOL
ISSN / eISSN
0167-8140 / 1879-0887
Aims and Scope
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.
Subject Area
ONCOLOGY
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
10.50
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Medicine - Radiology, Nuclear Medicine and Imaging | Q1 | #22/312 |
Medicine - Oncology | Q1 | #45/366 |
Medicine - Hematology | Q1 | #17/129 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2023) | Quartile |
---|---|
ONCOLOGY - SCIE | Q2 |
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING - SCIE | Q1 |
H-index
140
Country/Area of Publication
NETHERLANDS
Publisher
Elsevier Ireland Ltd
Publication Frequency
Monthly
Year Publication Started
1983
Annual Article Volume
351
Open Access
NO
Contact
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000
Verified Reviews
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started